Side by side
Consultation participation and their own register declarations, side by side. Counts, not judgments — participation is not influence.
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Public authority · Finland
NGO · Belgium
Declared costs: not declared · in the register since 2019
Medicinal products for human use · EU Chemicals Strategy for sustainability - Revision of the Cosmetic Products Regulation
Register facts self-declared (snapshot 2 Sept 2026); cost bands are floors. Shared files are shared attention, not evidence of coordination.
Their opening passages on the files they share, verbatim and in filing order. We do not summarize, compare, or characterize positions — read them at source.
Ministry of Social Affairs and Health · filed 27 Apr 2021 · source
Finland would like to thank for the possibility to comment and in general, we are in favour of the revision of the pharmaceutical legislation. The regulatory system should be sound and flexible, the legislative framework must not be too detailed, and the administrative burden must not be increased. It is important to make processes as streamlined and cost-effective as possible and to avoid inefficiency.
Cruelty Free Europe · filed 27 Apr 2021 · source
To achieve the goal of safe and affordable medicines and to support the European pharmaceutical industry to innovate, the Commission must put humane and human-relevant preclinical assessment at the heart of this strategy. Currently 90% of drugs fail in clinical trials on humans despite having passed pre-clinical studies, including extensive tests in animals.
Cruelty Free Europe · filed 8 Nov 2023 · source
Thank you for the opportunity to provide feedback on the proposed revisions to the EU general pharmaceuticals legislation. Cruelty Free Europe welcomes the provisions that support a shift away from testing on animals and towards greater use of non-animal methods this would advance many of the goals of the revision including addressing unmet medical needs, improving competitiveness, fostering innovation, improving…
Cruelty Free Europe · filed 8 Nov 2023 · source
Thank you for the opportunity to provide feedback on the proposed revisions to the EU general pharmaceuticals legislation. Cruelty Free Europe welcomes the provisions that support a shift away from testing on animals and towards greater use of non-animal methods this would advance many of the goals of the revision including addressing unmet medical needs, improving competitiveness, fostering innovation, improving…
Cruelty Free Europe · filed 29 Oct 2021 · source
The revision of the CPR provides an opportunity to ensure that cosmetics and their ingredients are not tested on animals. Cruelty Free Europe is disappointed to see that the initiative does not aim to protect and strengthen the animal testing bans, for which there is overwhelming public and political support.
Ministry of Social Affairs and Health · filed 1 Nov 2021 · source
The Finnish Ministry of Social Affairs and Health and the Finnish Safety and Chemicals Agency fully support the Commission’s high ambitions for a toxic-free environment leading to zero pollution. We want to thank the Commission for the possibility to provide feedback regarding the Commission’s Inception Impact Assessment (IIA) on the revision of the Cosmetic Products Regulation.
2 organizations on one sheet: every file each filed on, their register declarations, and a working link to each submission. Free: we ask for your name and email, and PolicySpeak may contact you about the product (privacy policy). The per-file record stays downloadable without signing up on each file’s page.